Table 3. Clinical characteristics of women with polycystic ovary syndrome with anxiety (HADS≥11) and without anxiety (HADS<11).
| (Anxiety HADS≥11) (n=33) |
Without anxiety (HADS<11) (n=87) |
p | |
|---|---|---|---|
| Age (years) median±IQR | 27.0±9.0 (18–40) | 25.0±5.0 (16–44) | 0.1281 |
| BMI (kg/m2) median±IQR | 24.9±8.6 (17.4–35.9) | 26.2±7.3 (17.9–45.8) | 0.4721 |
| Oligo/amenore (%) | 25 (75.8) | 58 (66.7) | 0.3362 |
| Irregular menstruation (%) | 28 (84.8) | 39 (44.8) | <0.001 2 |
| Ferriman-Gallwey score median±IQR | 9.0±6.0 (5–18) | 7.0±5.0 (0–17) | <0.001 1 |
| FSH median±IQR | 5.7±(1.8) (2.2–9.9) | 5.6±(1.8) (1.2–10) | 0.8921 |
| LH median±IQR | 10.8±(7.3) (4.7–21) | 7.3±(4.0) (1.4–17.0) | 0.001 1 |
| LH:FSH median±IQR | 2.1±(1.0) (0.7–5.5) | 1.3±(0.6) (0.4–3.5) | 0.003 1 |
| DHEA-SO4 median±IQR | 230±(87.5) (70.4–412) | 220±(87.0) (55.8–405) | 0.7111 |
| Prolactin median±IQR | 18.6±(13.7) (7.6–55.6) | 14.9±(10.8) (1.0–56.9) | 0.1091 |
| Total testosterone median±IQR | 0.4±(0.3) (0.2–0.9) | 0.3±(0.2)(0.1–0.7) | 0.040 1 |
| TSH median±IQR | 1.8±(1.2) (0.7–4.7) | 1.8±(1.5) (0.3–6.5) | 0.9811 |
| Estradiol (E2) median±IQR | 44.0±(19.5) (26–106) | 48.0±(25.3) (11–170) | 0.4861 |
1
Mann-Whitney U test.
2
Chi-square test.
BMI: body mass index; FSH: follicle-stimulating hormone; LH: follicle-stimulating hormone; LH/FSH: the ratio of luteinizing hormone to follicle-stimulating hormone; DHEA-SO4: dehydroepiandrosterone sulfate; TSH: thyroid-stimulating hormone; HADS: Hospital Anxiety and Depression Scale. Bold indicates statistically significant p-values.